BIOSYNTHESIS OF THE ANSAMYCIN ANTIBIOTIC RIFAMYCIN - DEDUCTIONS FROM THE MOLECULAR ANALYSIS OF THE RIF BIOSYNTHETIC GENE-CLUSTER OF AMYCOLATOPSIS-MEDITERRANEI S699
Pr. August et al., BIOSYNTHESIS OF THE ANSAMYCIN ANTIBIOTIC RIFAMYCIN - DEDUCTIONS FROM THE MOLECULAR ANALYSIS OF THE RIF BIOSYNTHETIC GENE-CLUSTER OF AMYCOLATOPSIS-MEDITERRANEI S699, Chemistry & biology, 5(2), 1998, pp. 69-79
Background: The ansamycin class of antibiotics are produced by various
Actinomycetes. Their carbon framework arises from the polyketide path
way via a polyketide synthase (PKS) that uses an unusual starter unit.
Rifamycin (rif), produced by Amycolatopsis mediterranei, is the arche
type ansamycin and it is medically important. Although its basic precu
rsors (3-amino-5-hydroxy benzoic acid AHBA, and acetic and propionic a
cids) had been established, and several biosynthetic intermediates had
been identified, very little was known about the origin of AHBA nor h
ad the PKS and the various genes and enzymes that modify the initial i
ntermediate been characterized. Results: A set of 34 genes clustered a
round the rifK gene encoding AHBA synthase were defined by sequencing
all but 5 kilobases (kb) of a 95 kb contiguous region of DNA from A. m
editerranei. The involvement of some of the genes in the biosynthesis
of rifamycin B was examined, At least five genes were shown to be esse
ntial for the synthesis of AHBA, five genes were determined to encode
the modular type I PKS that uses AHBA as the starter unit, and 20 or m
ore genes appear to govern modification of the polyketide-derived fram
ework, and rifamycin resistance and export. Putative regulatory genes
were also identified. Disruption of the PKS genes at the end of rifA a
bolished rifamycin B production and resulted in the formation of P8/1-
OG, a known shunt product of rifamycin biosynthesis, whereas disruptio
n of the orf6 and orf9 genes, which may encode deoxysugar biosynthesis
enzymes, had no apparent effect. Conclusions: Rifamycin production in
A. mediterranei is governed by a single gene cluster consisting of st
ructural, resistance and export, and regulatory genes. The genes chara
cterized here could be modified to produce novel forms of the rifamyci
ns that may be effective against rifamycin-resistant microorganisms.